PASS statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Bioactivity prediction Chemical toxicity Pharmacogenetics Drug repositioning chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

PASS specifications

Information


Unique identifier OMICS_18393
Name PASS
Alternative name Prediction of Activity Spectra for Substances
Software type Package/Module
Interface Graphical user interface
Restrictions to use License purchase required
Input data A 2D structural formula of chemical compound.
Input format MOL, SD
Output data Some pharmacotherapeutic effects, biochemical mechanisms, toxicity, metabolism, gene regulation expression, transporter-related activities.
Operating system Mac OS, Windows
Computer skills Medium
Version 11.4.12
Stability Stable
Maintained Yes

Versioning


Add your version

Documentation


Maintainer


  • person_outline Marc Nicklaus <>

Additional information


A registration is needed to access to tool.

Publications for Prediction of Activity Spectra for Substances

PASS in publications

 (2)
PMCID: 4189283
PMID: 25298685
DOI: 10.4103/0973-1296.139809

[…] states, tautomers, stereochemistries and ring conformations. the energy minimized compounds were subjected to biological activity prediction based on their structural orientation using pass (prediction of activity spectra for substances) tool.[], the pass prediction results also showed that these compounds have anti-pulmonary hypertension property. based on the results of in vitro, […]

PMCID: 2680638
PMID: 19468330
DOI: 10.3390/ijms10041628

[…] with the human organism has been elucidated through absorption, distribution, metabolism and excretion data derived by adme boxes [] and the human toxicological effects by toxboxes [] and by pass (prediction of activity spectra for substances) []., the epi suite has been applied as the primary tool for generating physico-chemical endpoints []. this software package includes a variety […]


To access a full list of publications, you will need to upgrade to our premium service.

PASS institution(s)
Laboratory of Structure-Function Based Drug Design, V.N. Orekhovich Institute of Biomedical Chemistry of the Russian Academy of Medical Sciences, Moscow, Russia; Computer Chemistry Center and Institute for Organic Chemistry, University of Erlangen-Nurnberg, Erlangen, Germany; Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute, National Institutes of Health, NCI-Frederick, Frederick, MD, USA
PASS funding source(s)
Supported by the U.S. Civil Research and Development Foundation (Grant # RC1-2064).

PASS reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review PASS